Home > Income Statement > IPCA LABORATORIES

IPCA LABORATORIES
Consolidated Net Profit

    Back to Income Statement
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

IPCA LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹547 Cr₹471 Cr₹884 Cr₹1,140 Cr₹606 Cr

What is the latest Consolidated Net Profit of IPCA LABORATORIES ?

The latest Consolidated Net Profit ratio of IPCA LABORATORIES is ₹547 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹547 Cr
Mar2024₹471 Cr
Mar2023₹884 Cr
Mar2022₹1,140 Cr
Mar2021₹606 Cr

How is Consolidated Net Profit of IPCA LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹547 Cr
16.13
Mar2024 ₹471 Cr
-46.69
Mar2023 ₹884 Cr
-22.45
Mar2022 ₹1,140 Cr
88.02
Mar2021 ₹606 Cr -

Compare Consolidated Net Profit of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹38,676.6 Cr 4.1% 5.3% 3.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

4.1%

5.3%

3.7%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses